drugset / Trial / NCT04649073
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the tolerability,safety and efficacy of OPC-415 in patients with relapsed and/or refractory Multiple Myeloma (MM).
Timeline
- Start
- 2021-02-18
- Primary completion
- 2025-04-09
- Completion
- 2041-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OPC-415 | Unknown | 1e+07 cells/kg | — |